Summit Therapeutics Inc (SMMT)
15.68
-2.73%
Summit Therapeutics Inc (SMMT) is currently trading at $15.68. This represents a loss of 2.73% from the previous session. With a market capitalization of $12.21B, SMMT is a key component of the Health Care sector. Investors looking to trade SMMT should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Claim Your $300 Cash Bonus →
T&Cs Apply. Trade SMMT commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Summit Therapeutics Inc (SMMT) shows a bearish trend. Analysts are watching the 16.51 level closely.
Fundamentals
Mkt Cap12.21B
P/E Ratio0.0000
Volume1,525,551
60-Day Technical Chart
Advanced Charting
Need more indicators for SMMT? Use the world's #1 platform.
Open SMMT on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $16
| Metric |
SMMT -2.73% |
F +1.62% |
HIMS +2.33% |
CIFR -2.98% |
|---|---|---|---|---|
| Price | $15.68 | $14.43 | $15.82 | $16.61 |
| Mkt Cap | $12.21B | $57.57B | $3.63B | $6.61B |
| - | View → | View → | View → |
Latest Headlines
Summit Therapeutics posts $1.08B loss, FDA accepts lung cancer BLA
Stock Titan • Feb 23, 2026
SMMT: Analyst Lowers Price Target to $30, Maintains Buy Rating |
GuruFocus • Feb 24, 2026
Summit Therapeutics (SMMT) Valuation Check After Recent Share Price Pullback And Conflicting Model Signals
Yahoo Finance • Jan 30, 2026
$SMMT stock is down 5% today. Here's what we see in our data.
Quiver Quantitative • Jan 23, 2026
Assessing Summit Therapeutics (SMMT) Valuation After Ivonescimab FDA Filing And New GSK Trial Collaboration
Sahm • Jan 14, 2026
● Gemini Agentic AI Analyst Insight for SMMT
Market Education
- The Basics of the Stock Market for Beginners Aug 25, 2023
- Stocks with Cash and Low Debt Dec 10, 2023
- Blackrock Top Stocks Nov 20, 2023
External Research